Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?
PLOS Pathogens · 30.03.2023 · 19 (3) · e1011223
DOI: 10.1371/journal.ppat.1011223 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 30.03.2023. Verfasst von Andrew Teo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. Hauptthemen laut MEDLINE: Antibody-Dependent Enhancement, Dengue. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education (MOE) Fundamental Research Grant Scheme of Malaysia, Lee Kong Chian School of Medicine, Nanyang Technological University.
Abstract (Originalsprache)
Dengue is a mosquito-borne infection caused by dengue virus (DENV) of the Flaviviridae family.There are four distinct serotypes, DENV-1,-2,-3,-4, which cause outbreaks globally.Infection is often self-resolving, and lifelong immunity against the infecting serotype can be achieved after exposure.However, in some individuals, homologous infection may still result in symptomatic dengue [1].There is usually limited protection against heterotypic infections by three other DENV serotypes, as cross-protection is short-lived [2].After this window of "protection", subsequent infection with a different serotype may increase the risk of developing severe dengue [3,4].Antibody-dependent enhancement (ADE) in dengue, a process mainly mediated by immunoglobulin G (IgG), is believed to be one of the major underlying mechanisms leading to increased severity in secondary DENV infection.ADE was shown to enhance viral entry into immune cells via their Fcγ receptors (FcγR), which promotes viral replication, leading to increased viremia and pro-inflammatory responses.These contribute to disease pathologies including vascular hyperpermeability, a common cause of severe dengue [5].Although this pathological link was first reported about six decades ago, the inherent molecular mechanisms are still not fully understood.Here, we discuss the current model of ADE in dengue and provide new perspective on the possible roles of afucosylated IgG1s in ADE-mediated severe dengue. ViralAU : Pleaseconfirmthatallheadinglevelsarerepresentedcorrectly: and host factors in influencing ADE in dengueDENV has a positive-sense RNA genome that encodes for seven nonstructural proteins and three structural glycoproteins (the capsid shell, envelope (E) and premembrane (prM) proteins) that are responsible for virus attachment, entry, and maturation [6].Although all serotypes are closely related, a significant degree of sequence diversity exists [4].As a result, a subset of IgGs that target viral proteins from one serotype may cross-react with those from other serotypes and exhibit poor neutralising function.For instance, the noninfectious immature virions have a "spiky" appearance, because of higher surface exposure of immunodominant epitopes (pr fragment of the prM proteins and fusion loop in the E proteins) [7].These epitopes are recognised by low levels of cross-reactive IgGs, promoting entry into FcγR-bearing cells that lead to infectious virus maturation and immune suppression that favours viral replication [4,8,9].Additionally, decreased neutralising antibody concentrations due to waning immunity may
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
- National Centre for Infectious Diseases, Singapore, Singapore.
- Department of Medicine, The Doherty Institute, University of Melbourne, Melbourne, Australia.
- School of Biosciences, Faculty of Health and Medicine Sciences, Taylor's University, Subang Jaya, Malaysia.
- A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
- Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.
ORCID-Profile: Andrew Teo
Förderung
- Ministry of Education (MOE) Fundamental Research Grant Scheme of Malaysia
- Lee Kong Chian School of Medicine, Nanyang Technological University
Zitieren
APA
Teo, A., Tan, H. D., Loy, T., Chia, P. Y., & Chua, C. L. L. (2023). Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?. PLOS Pathogens, 19(3), e1011223. https://doi.org/10.1371/journal.ppat.1011223
Vancouver
Teo A, Tan HD, Loy T, Chia PY, Chua CLL. Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?. PLOS Pathogens. 2023;19(3):e1011223. doi:10.1371/journal.ppat.1011223
BibTeX
@article{Teo2023,
author = {Teo, Andrew and Tan, Hao Dong and Loy, Thomas and Chia, Po Ying and Chua, Caroline Lin Lin},
title = {Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?},
journal = {PLOS Pathogens},
year = {2023},
volume = {19},
number = {3},
pages = {e1011223},
doi = {10.1371/journal.ppat.1011223}
}
EUVIMED